Bank Of America Corp Checkpoint Therapeutics, Inc. Transaction History

Bank Of America Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.53 - $3.25 $338,278 - $718,565	-221,097 Reduced 95.67%	10,002 $18,000
Q4 2021 Feb 08, 2022	BUY	$2.68 - $4.46 $551,627 - $918,006	205,831 Added 814.59%	231,099 $719,000
Q3 2021 Nov 15, 2021	SELL	$2.5 - $3.53 $87,680 - $123,804	-35,072 Reduced 58.12%	25,268 $83,000
Q2 2021 Sep 13, 2021	BUY	$2.36 - $3.2 $142,402 - $193,088	60,340 New	60,340 $178,000

1.91M

Ticker CKPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 85,497,000
Market Cap $245M
Description
Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.